Clinical Trial Update: A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis

View source ↗

Summary

A completed clinical study evaluated the use of omalizumab for food allergy and related anaphylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaphylaxis
• Food Allergy

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Food Hypersensitivity, Anaphylaxis | Status: COMPLETED